These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2409371)

  • 1. Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.
    Mace PJ; Littler WA; Glover DR; Rowlands DB; Stallard TJ
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S52-5. PubMed ID: 2409371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indapamide in rats with pressure overload left ventricular hypertrophy.
    Böcker W; Hupf H; Grimm D; Kurzidim K; Schunkert H
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):481-6. PubMed ID: 11026649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.
    Leenen FH; Burns RJ; Myers MG; Frankel D
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):499-504. PubMed ID: 1981020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy.
    Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of indapamide in left ventricular hypertrophy in patients with hypertension].
    Komajda M; Klimczak K; Evans J; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():45-50. PubMed ID: 2150474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine.
    Schulte KL; Meyer-Sabellek W; Liederwald K; van Gemmeren D; Lenz T; Gotzen R
    Am J Cardiol; 1992 Aug; 70(4):468-73. PubMed ID: 1386490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine-GITS on left ventricular mass and left ventricular filling.
    Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S28-34. PubMed ID: 1377301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy by acebutolol and nifedipine.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():313-7. PubMed ID: 2535068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Br J Clin Pharmacol; 1986 Jun; 21(6):633-40. PubMed ID: 3527242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.